ABCG2 and malignant glioma: In a study by Martin et al., melatonin has been found to increase DNMT activity, increase ABCG2 promoter methylation and downregulate ABCG2 expression in malignant glioma cells as well as in a subpopulation of brain cancer stem cells [191].